Table 2. Prevalence and type distribution of high-risk HPV genotypes in cancerous, benign and normal breast tissue specimens.
| Pathological Status | HPV Genotype | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HPV Positive Cancerous Cases n = 35 | 16 | 31 | 33 | 35 | 18 | 39 | 45 | 59 | 52 | 56 | 58 | 66 |
| In Situ Cases | ||||||||||||
| Ductal Carcinoma In Situ (DCIS) (8) | 2 | 1 | — | 2 | 2 | 3 | 2 | — | 1 | — | 1 | — |
| Lobular Carcinoma In Situ (LCIS) (1) | — | — | — | — | — | — | — | 1 | — | — | — | — |
| Invasive Cases | ||||||||||||
| Invasive Ductal Carcinoma (IDC) (10) | 1 | 3 | 3 | 3 | 2 | 4 | 2 | 2 | 1 | 1 | 1 | — |
| Invasive Lobular Carcinoma (ILC) (5) | — | 1 | — | 1 | 1 | 2 | 2 | 1 | — | — | 1 | — |
| Invasive and In Situ Cases | ||||||||||||
| Invasive & In Situ Ductal Carcinoma (8) | 4 | — | — | — | 2 | 4 | 2 | 3 | — | — | 1 | — |
| Invasive & In Situ Lobular Carcinoma (3) | — | — | 1 | 1 | — | — | — | — | — | — | — | |
| Total Prevalence of Specific HPV Genotype Cases n = | 7 | 5 | 3 | 7 | 8 | 13 | 8 | 7 | 2 | 1 | 4 | — |
| HPV Positive Benign and Normal Cases n = 11 | 16 | 31 | 33 | 35 | 18 | 39 | 45 | 59 | 52 | 56 | 58 | 66 |
| Benign Tissue (6) | 2 | 1 | — | 1 | — | 1 | 1 | 1 | — | — | 2 | — |
| Benign Tissue (previous cancer) (1) | — | — | — | — | 2 | — | — | — | — | — | — | — |
| Papilloma (3) | 1 | — | 1 | — | 1 | 2 | 1 | 1 | — | — | — | — |
| Cosmetic reduction (1) | 1 | — | — | — | — | — | — | — | — | — | — | — |
| Total Prevalence of Specific HPV Genotype Cases n= | 4 | 1 | 1 | 1 | 3 | 3 | 2 | 2 | — | — | 2 | — |
(−) negative results.